Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.Psychopharmacology · 2025-10-10Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Unknown journal · 2022-07-27Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controlsVIUspace · 2022-06-29Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Scientific Reports · 2022-06-29Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific Reports · 2021-11-17Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.Frontiers in psychiatry · 2020-12-31